Crossmark

Monitoring monocyte HLA-DR expression and CD4 + T lymphocyte count in dexamethasone-treated severe COVID-19 patients

Crossref DOI link: https://doi.org/10.1186/s13613-024-01310-5

Published Print: 2024

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Monneret, Guillaume https://orcid.org/0000-0002-9961-5739
Voirin, Nicolas

Richard, Jean-Christophe

Cour, Martin

Rimmelé, Thomas

Garnier, Lorna

Yonis, Hodane

Coudereau, Remy

Gossez, Morgane

Malcus, Christophe

Wallet, Florent

Delignette, Marie-Charlotte

Dailler, Frederic

Buisson, Marielle

Argaud, Laurent

Lukaszewicz, Anne-Claire

Venet, Fabienne

Pescarmona, Remi

Lombard, Christine

Perret, Magali

Villard, Marine

Groussaud, Marie

Itah, Laetitia

Boussaha, Inesse

Poitevin-Later, Françoise

Simon, Marie

Dargent, Auguste

Bertrand, Pierre-Jean

Stevic, Neven

Provent, Marion

Bignet, Laurie

Cerro, Valérie

Bitker, Laurent

Mezidi, Mehdi

Baboi, Loredana
Funding

Funding for this research was provided by:

Fondation Hospices Civils de Lyon (--)

Fondation HCL (--)

Université Claude Bernard Lyon 1 (--)

Région Auvergne-Rhône-Alpes (--)
License Information

Text and Data Mining valid from 2024-01-01

Text and Data Mining valid from 2024-01-01

Version of Record valid from 2025-11-19
More Information

This article is maintained by: Elsevier

Article Title: Monitoring monocyte HLA-DR expression and CD4 + T lymphocyte count in dexamethasone-treated severe COVID-19 patients

Journal Title: Annals of Intensive Care

CrossRef DOI link to publisher maintained version: https://doi.org/10.1186/s13613-024-01310-5

Content Type: article

Copyright: Copyright © 2024 The Author(s) 2024. Published by Elsevier Masson SAS